期刊文献+

炎琥宁辅助治疗支原体肺炎的临床疗效观察

The inflammation amber is rather auxiliary the treatment Mycoplasma pneumonia the clinical curative effect observation
下载PDF
导出
摘要 目的:探讨炎琥宁辅助治疗支原体肺炎的临床疗效。方法:根据我院门诊2008年2月~2010年2月收治的80例肺炎支原体肺炎患者的临床资料,随机分为:治疗组(40例)和对照组(40例),对照组患儿采用肺炎常规治疗方案,治疗组患者在常规治疗的基础上加用炎琥宁辅助治疗,比较两组患者的临床疗效以及药物的不良反应。结果:炎琥宁治疗儿童支原体肺炎效果明显,优于对照组,治疗组:有效果为22例,显著疗效为10例,无效果为8例,有效率达80%;对照组:有效果为17例,显著疗效为10例,无效果为13例,有效率67.5%,两组疗效差异有统计学意义(p<0.05)。两组患儿均未发生药物不良反应。结论:炎琥宁辅助治疗支原体肺炎,能减轻患儿的不适症状,疗效满意,值得在临床推广。 Goal: The discussion inflammation amber is rather auxiliary the treatment Mycoplasma pneumonia the clinical curative effect. Method: 80 example pneumonia Myceplasma pneumonia patient~ clinical material which in February, 2008 -2010 year in February admits according to my courtyard outpatient service, divides into stochastically: The treatment group (40 examples) and the control group (40 examples), the control group babies use pneumonia convention therapeutic schedule, the treatment group patients add in the conventional treatment foundation with the inflammation amber are rather auxiliary treat, compared with two group of patient~ clinical curative effects as well as medicine untoward effect. Finally: The inflammation amber rather treats the child Mycoplasma pneumonia effect to be obvious, surpasses the control group, the treatment group: Some effects are 22 examples, the remarkable curative effect is 10 examples, does not have the effect is 8 examples, effectiveness reaches 80% ; Control group: Some effects are 17 examrples, the remarkable curative effect is 10 examples, does not have the effect is 13 examples, effectiveness 67.5% , two group of curative effect differences has statistics significance ( p 〈 0.05 ). Two group of babies have not had the medicine untoward effect. Conclusion: The inflammation amber is rather auxiliary the treatment Mycoplasma pneumonia, can reduce baby's ill symptom, the curative effect is satisfied, is worth in clinical promoting.
作者 孙广枪
出处 《求医问药(下半月刊)》 2011年第3期139-139,共1页 Seek Medical and Ask The Medicine
关键词 小儿支原体肺炎 炎琥宁 肺功能 临床疗效 Young child Mycoplasma pneumonia Inflammation amber rather Lung function Clinical curative effect
  • 相关文献

参考文献3

二级参考文献29

  • 1罗炜,赖克方,钟南山.诱导痰检测的方法学及其在气道炎症评价中的应用[J].国外医学(呼吸系统分册),2004,24(6):395-397. 被引量:22
  • 2曹玉璞.儿童肺炎支原体感染血清流行病学调查[J].中华流行病学杂志,1986,7(3):157-157.
  • 3胡亚美 江载芳.诸福棠实用儿科学[M](第7版)[M].北京:人民卫生出版社,2002.1199-1201.
  • 4吴瑞萍 胡亚美 江载芳.诸福棠实用儿科学[M]第6版[M].北京:人民卫生出版社,1996.753-759.
  • 5Pin I,Gibson PG,Kolendowice R, et al. Use of induced sputum cell counts to investigate airway in flammation in asthma[J ]. Thorax J,1992,479(1):25-29.
  • 6Koh YY, Park Y, Lee H J, et al. Levels of interleukin-2, interferongamma, and interleukin-4 in bronchoalveolar lavage fluid from patients with Mycoplasma pneumonia: implication of tendency toward increased immunoglobulin E production [J ]. Pediatr J, 2001, 107(3):39-43.
  • 7成田光先.小儿マィコプラズマ肺炎の临床[J].临床と微生物,2003,30(1):47-51.
  • 8Narita M,Tanaka H,Abe S.et al.Close association between pulmonary disease manifestation in Mycoplasma pneumoniae infection and enhanced local production of interleukin-18 in the lung independent of gamma interferon[J].Clin Diagn Lab Immunol,2000,7(6):909-914.
  • 9Narita M,Tanaka H,Yamada S,et al.Significant role of interleukin-8 in pathogenesis of pulmonary disease due to Mycoplasma pneumoniae infection.Clin Diagn Lab Immunol[J].2001,8(5):1028-1030.
  • 10Tanaka H,Narita M,Teramoto S,et al.Role of interleukin-18 and T-helpor type I cytokines in the development of Mycoplasma preuminiae pneumonia in adults[J].Chest,2002,121(5):1493-1497.

共引文献110

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部